“Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 5-year Analysis of the KEEPsAKE 1 and 2 Trials”, J of Skin, vol. 9, no. 6, p. s691, Nov. 2025, doi: 10.25251/pwq1v445.